DK1247521T3 - Use of biguanide and pyrimidine derivatives for the preparation of topical skincare preparations - Google Patents

Use of biguanide and pyrimidine derivatives for the preparation of topical skincare preparations

Info

Publication number
DK1247521T3
DK1247521T3 DK02290659T DK02290659T DK1247521T3 DK 1247521 T3 DK1247521 T3 DK 1247521T3 DK 02290659 T DK02290659 T DK 02290659T DK 02290659 T DK02290659 T DK 02290659T DK 1247521 T3 DK1247521 T3 DK 1247521T3
Authority
DK
Denmark
Prior art keywords
skin
biguanide
acne
preparation
pyrimidine derivatives
Prior art date
Application number
DK02290659T
Other languages
Danish (da)
Inventor
Andre Salkin
Original Assignee
Andre Salkin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andre Salkin filed Critical Andre Salkin
Application granted granted Critical
Publication of DK1247521T3 publication Critical patent/DK1247521T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The use of one or more biguanide derivatives (I) and one or more pyrimidines (II) is claimed in the production of cosmetic care compositions for young skin or skin with a tendency to acne or pharmaceutical compositions for treating blemished young skin or skin affected by acne or inflammatory or retentional lesions. Independent claims are included for: (i) cosmetic compositions or pharmaceutical compositions for use as above, containing (I) and (II) at a combined concentration lower than the minimum inhibitory concentration for strain(s) characteristic of acne; and (ii) a cosmetic care method, involving topical application of a composition containing (I) and (II) to the appropriate regions of the skin.
DK02290659T 2001-03-15 2002-03-15 Use of biguanide and pyrimidine derivatives for the preparation of topical skincare preparations DK1247521T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0103510A FR2822070B1 (en) 2001-03-15 2001-03-15 USE OF A BIGUANIDE DERIVATIVE AND A PYRIMIDINE FOR THE MANUFACTURE OF A COSMETIC CARE COMPOSITION

Publications (1)

Publication Number Publication Date
DK1247521T3 true DK1247521T3 (en) 2005-03-14

Family

ID=8861150

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02290659T DK1247521T3 (en) 2001-03-15 2002-03-15 Use of biguanide and pyrimidine derivatives for the preparation of topical skincare preparations

Country Status (6)

Country Link
EP (1) EP1247521B1 (en)
AT (1) ATE282404T1 (en)
DE (1) DE60201935T2 (en)
DK (1) DK1247521T3 (en)
ES (1) ES2233778T3 (en)
FR (1) FR2822070B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2858232B1 (en) * 2003-07-29 2006-03-03 Pierre Potier USE OF A BIGUANIDE DERIVATIVE TO PROTECT THE SKIN FROM UVB RADIATION
JP2007536233A (en) * 2004-05-03 2007-12-13 ネオシル インコーポレーテッド Treatment with polycationic antibacterial drugs
GB201112657D0 (en) * 2011-07-22 2011-09-07 Lowe Nicholas J Compositions for treatment of skin disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2552305B1 (en) * 1983-09-22 1985-12-20 Salkin Andre HIGH BACTERICIDAL COMPOSITION CONTAINING BIGUANIDE AND PYRIMIDINE
US5114943A (en) * 1984-03-19 1992-05-19 The Rockefeller University Amino-substituted pyrimidines, derivatives and methods of use therefor
DE3702983A1 (en) * 1986-06-09 1987-12-10 Henkel Kgaa DISINFECTANT AND THEIR USE FOR SKIN AND MUCUS SKIN DISINFECTION
CA1273576A (en) * 1987-09-16 1990-09-04 Patrick A. Beauchamp Topical treatment for diseased skin disorders
KR960004500B1 (en) * 1992-10-20 1996-04-06 주식회사유공 A sterilizing detergent composition
WO1995004520A1 (en) * 1993-08-06 1995-02-16 Embro William J Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection
CA2151774C (en) * 1994-06-27 1999-04-06 Minh Quang Hoang Skin disinfecting formulations
AT408067B (en) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
EP1247521A1 (en) 2002-10-09
FR2822070B1 (en) 2006-01-06
DE60201935T2 (en) 2005-06-30
EP1247521B1 (en) 2004-11-17
FR2822070A1 (en) 2002-09-20
ES2233778T3 (en) 2005-06-16
ATE282404T1 (en) 2004-12-15
DE60201935D1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
DE602005027811D1 (en) IONIC UV-A SUN PROTECTION AGENTS AND COMPOSITIONS CONTAINING THEM
WO2004037184A3 (en) Methods for the treatment of skin disorders
ATE311849T1 (en) USE OF COSMETIC AND PHARMACEUTICAL PREPARATIONS CONTAINING 2-DECARBOXY-2-PHOSPHINO PROSTAGLAND INDIVIDUALS
WO2006099187A3 (en) Benzoyl peroxide compositions and methods of use
DK1439832T3 (en) Method of treating acne vulgaris using an avermectin compound
DE60329994D1 (en) Self-tanner containing water-soluble vitamin B3 component and tanning active with alpha-hydroxycarbonyl grouping
DE3681647D1 (en) PREPARATION WITH EFFECT AGAINST ACNE AND USE OF ACTIVE SUBSTANCE EXTRACT OF MERCURY WHEAT.
WO2008122517A3 (en) Sunscreen compositions comprising a random terpolymer
DK1635776T5 (en) Lipid transfer protein systems as well as their cosmetic dermatological application
DK0700898T3 (en) L-carnitine salt and cosmetic and pharmaceutical preparations containing the same, for the treatment of dermatoses.
DE602005025495D1 (en) DERIVATIVES OF AN ARYLSULFONAMIDOSUBSTITUTED HYDROXAMIC ACID AS MATRIX METALLOPROTEINASE INHIBITORS
DE602005008635D1 (en) COSMETIC COMPOSITIONS
ATE256392T1 (en) USE OF POLYAMINO ACID DERIVATIVES AS PRESERVATIVES
EP1172084A3 (en) Cosmetic and dermatologic composition to eliminate sebum
MX2023000870A (en) Diester cosmetic formulations and uses thereof.
SG161309A1 (en) Hair tonic
ATE521331T1 (en) USE OF BIS-RESORCINYLTRIAZINE DERIVATIVES IN COSMETIC OR DERMATOLOGICAL PREPARATIONS
PA8525801A1 (en) PIRAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS TO MODULATE AND / OR INHIBIT THE ACTIVITY OF ERAB / HADH2
BR0211784A (en) Method for reducing human hair growth, use of alpha-difluoromethylornithine, and cosmetic composition used for reducing human hair growth
ATE329604T1 (en) USE OF AN ANTIOXIDANT COMPOSITION CONTAINING MOZUKU ALGAE EXTRACT
DK1247521T3 (en) Use of biguanide and pyrimidine derivatives for the preparation of topical skincare preparations
DK0700897T3 (en) L-carnitine salt and cosmetic and pharmaceutical preparations containing the same for the treatment of skin diseases
ATE280570T1 (en) COMPOSITION CONTAINING CAFFEINE AS A MAIN CARE PRODUCT
PL1495753T3 (en) Use of (2S,3R,4S)-4-hydroxyisoleucine in cosmetic compositions for topical application.
PT1232173E (en) FUSIDIC ACID DERIVATIVES